The Market for Organ and Tissue Transplantation and Alternatives

U.S. ORGAN AND TISSUE TRANSPLANTATION MARKET TO REACH $15.1 BILLION BY 2010

Organ failure and tissue loss account for half the medical spending in the U.S. In theory, transplantation is the last therapeutic option available to people in the final stage of an organ or tissue failure. In reality, the supply of organs or tissues is so limited that for the vast majority of people, transplantation is not an option. At the same time, transplantation outcomes are under renewed scrutiny as insurers try to control healthcare costs.

According to a soon-to-be-released updated technical market research report, RB-103N The Market for Organ and Tissue Transplantation and Alternatives from Business Communications Company, Inc. (www.bccresearch.com), the organ and tissue transplantation market in the U.S. is estimated at $11.7 billion in 2005 and is expected to rise at an average annual growth rate (AAGR) of 5.2% to $15.1 billion by 2010. Growth for different types of products and services will vary greatly within the market, depending on how they relate to the dominant trends shaping transplantation.

The U.S. organ transplantation market is currently estimated at just under $5 billion and is projected to expand at an AAGR of 4.9%, reaching nearly $6.3 billion in 2010. The fastest growing sector within organ transplantation is small bowel (intestine) transplantation. It also is the newest sector, having been approved for reimbursement by Medicare in 2001. The largest sector is kidney transplantation, currently accounting for over 56.2% of U.S. organ transplants.

The primary factor driving the future of transplantation is the shortage of organs. Hence, there is great demand for anything that will increase supply, whether by increasing recovery from cadavers or bringing in a new supply from living donors, or by reducing waste. The latter category includes better preservation, repair of slightly damaged organs or tissues, and better anti-rejection drugs to reduce organ rejection.

Meanwhile, the rapid spread of organ transplant services increases the competition for both organs and patients. As of mid-June 2005, there were 255 transplant centers in the U.S. and hundreds more in some 80 other countries.

At the same time, the shortage of transplantable organs has created a window of opportunity for alternatives to transplantation. In the case of hearts and livers, those alternatives are beginning to emerge, and expanding use of alternatives to pancreas or human islet cell transplants soon may be available as well.

The U.S. tissue transplantation market (for the categories included in this report, i.e., corneas, bone marrow, bone grafts, heart valves and skin/skin replacement products) totaled approximately $6.8 billion in 2005 and is projected to grow at an AAGR of 5.5%, to approximately $8.9 billion in 2010. The number of procedures is expected to grow from 3.69 million in 2005 to 4.62 million in 2010.

U.S. Organ and Tissue Transplantation Markets, 2005 and 2010

U.S. Organ and Tissue Transplantation Markets, 2005 and 2010

RB-103N The Market for Organ and Tissue Transplantation and Alternatives - Updated Edition

Data and analysis extracted from this press release must be accompanied by a statement identifying BUSINESS COMMUNICATIONS COMPANY, INC., 25 Van Zant Street, Norwalk, CT 06855,  Telephone: (203) 853-4266; ext. 309,  Email: publisher@bccresearch.com as the source and publisher, along with report number, which can be found in the second paragraph of this relese. Thank you.